Literature DB >> 15655660

Chemical shift magnetic resonance spectroscopy of cingulate grey matter in patients with minimal hepatic encephalopathy.

Sergei Mechtcheriakov1, Michael Schocke, André Kugener, Ivo W Graziadei, Michael Mattedi, Hartmann Hinterhuber, Wolfgang Vogel, Josef Marksteiner.   

Abstract

Minimal hepatic encephalopathy (MHE) is frequently diagnosed in patients with liver cirrhosis who do not show overt clinical cirrhosis-associated neurological deficits. This condition manifests primarily with visuo-motor and attention deficits. We studied the association between visuo-motor deficits and magnetic resonance spectroscopic parameters in cingulate grey matter and white matter of centrum semiovale in patients with liver cirrhosis. The data revealed an increase in the glutamate-glutamine/creatine ratio and a decrease in choline/creatine and inositol/creatine ratios in patients with liver cirrhosis. The analysis of the data showed that cirrhosis-associated deterioration of the visuo-motor function significantly correlates with a decrease in the choline/creatine ratio and an increase in N-acetylaspartate/choline in cingulate grey matter but not in the neighbouring white matter. Furthermore, the increase in the glutamate-glutamine/creatine ratio correlated significantly with the increase in the N-acetylaspartate/creatine ratio. These data suggest an association between altered choline, glutamate-glutamine and NAA metabolism in cingulate grey matter and symptoms of MHE, and underline the importance of differentiation between grey and white matter in magnetic resonance spectroscopic studies on patients with cirrhosis-associated brain dysfunction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15655660     DOI: 10.1007/s00234-004-1298-8

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  35 in total

Review 1.  Early detection and treatment of hepatic encephalopathy.

Authors:  A H Lockwood
Journal:  Curr Opin Neurol       Date:  1998-12       Impact factor: 5.710

2.  Usefulness of magnetic resonance spectroscopy for diagnosis of hepatic encephalopathy in a patient with relapsing confusional syndrome.

Authors:  J Cordoba; C Hinojosa; F Sampedro; J Alonso; A Rovira; S Quiroga; R Esteban; J Guardia
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

3.  Neuropsychological aspects of portal-systemic encephalopathy.

Authors:  H Schomerus; W Hamster
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

4.  Attention deficits in minimal hepatic encephalopathy.

Authors:  K Weissenborn; S Heidenreich; J Ennen; N Rückert; H Hecker
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

5.  Relationship between cerebral perfusion in frontal-limbic-basal ganglia circuits and neuropsychologic impairment in patients with subclinical hepatic encephalopathy.

Authors:  A M Catafau; J Kulisevsky; L Bernà; J Pujol; J C Martin; P Otermin; J Balanzó; I Carrió
Journal:  J Nucl Med       Date:  2000-03       Impact factor: 10.057

6.  Screening of subclinical hepatic encephalopathy.

Authors:  M Groeneweg; W Moerland; J C Quero; W C Hop; P F Krabbe; S W Schalm
Journal:  J Hepatol       Date:  2000-05       Impact factor: 25.083

7.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

8.  Labeling of N-acetylaspartate and N-acetylaspartylglutamate in rat neocortex, hippocampus and cerebellum from [1-13C]glucose.

Authors:  R L Tyson; G R Sutherland
Journal:  Neurosci Lett       Date:  1998-07-31       Impact factor: 3.046

9.  Serial contrast-enhanced magnetic resonance imaging and spectroscopic imaging of acute multiple sclerosis lesions under high-dose methylprednisolone therapy.

Authors:  Michael F H Schocke; Thomas Berger; Stephan R Felber; Christian Wolf; Florian Deisenhammer; Christian Kremser; Klaus Seppi; Franz T Aichner
Journal:  Neuroimage       Date:  2003-10       Impact factor: 6.556

10.  Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy.

Authors:  S D Taylor-Robinson; J Sargentoni; C D Marcus; M Y Morgan; D J Bryant
Journal:  Metab Brain Dis       Date:  1994-12       Impact factor: 3.584

View more
  8 in total

Review 1.  The brain following transjugular intrahepatic portosystemic shunt: the perspective from neuroimaging.

Authors:  Hui Juan Chen; Gang Zheng; Julian L Wichmann; U Joseph Schoepf; Guang Ming Lu; Long Jiang Zhang
Journal:  Metab Brain Dis       Date:  2015-09-24       Impact factor: 3.584

2.  Abnormal spontaneous brain activity in minimal hepatic encephalopathy: resting-state fMRI study.

Authors:  Wei-Jia Zhong; Zhi-Ming Zhou; Jian-Nong Zhao; Wei Wu; Da-Jing Guo
Journal:  Diagn Interv Radiol       Date:  2016 Mar-Apr       Impact factor: 2.630

Review 3.  Recent advances in magnetic resonance neurospectroscopy.

Authors:  Yael Rosen; Robert E Lenkinski
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

4.  Minimal hepatic encephalopathy in children with liver cirrhosis: diffusion-weighted MR imaging and proton MR spectroscopy of the brain.

Authors:  Ahmed Abdel Khalek Abdel Razek; Ahmed Abdalla; Amany Ezzat; Ahmed Megahed; Tarek Barakat
Journal:  Neuroradiology       Date:  2014-07-25       Impact factor: 2.804

5.  Multidimensional assessment of neuro-psychiatric symptoms in patients with low-grade hepatic encephalopathy: a clinical rating scale.

Authors:  Sergei Mechtcheriakov; Ivo-W Graziadei; André Kugener; Julia Wiedemann; Chantal Galbavy; Hartmann Hinterhuber; Josef Marksteiner; Wolfgang Vogel
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

6.  Regional reduction in gray and white matter volume in brains of cirrhotic patients: voxel-based analysis of MRI.

Authors:  Motoh Iwasa; Rumi Mifuji-Moroka; Makoto Kuroda; Hideo Moroka; Naoki Fujita; Yoshinao Kobayashi; Yukihiko Adachi; Esteban C Gabazza; Hiroshi Matsuda; Yoshiyuki Takei
Journal:  Metab Brain Dis       Date:  2012-05-18       Impact factor: 3.584

7.  Motor dysfunction in patients with liver cirrhosis: impairment of handwriting.

Authors:  Sergei Mechtcheriakov; Ivo W Graziadei; André Kugener; Ingrid Schuster; Joerg Mueller; Hartmann Hinterhuber; Wolfgang Vogel; Josef Marksteiner
Journal:  J Neurol       Date:  2005-10-28       Impact factor: 4.849

8.  The effect of hepatic encephalopathy, hepatic failure, and portosystemic shunt on brain volume of cirrhotic patients: a voxel-based morphometry study.

Authors:  Long Jiang Zhang; Rongfeng Qi; Jianhui Zhong; Qiang Xu; Gang Zheng; Guang Ming Lu
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.